Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical course of patient no. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Fig 1 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 8 - حسب Farshid Maleki (20521649)

الموضوعات:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. حسب Farshid Maleki (20521649)

الموضوعات:

Fig 4 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 9 - حسب Farshid Maleki (20521649)

الموضوعات:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). حسب Farshid Maleki (20521649)

الموضوعات:

Fig 7 - حسب Farshid Maleki (20521649)

الموضوعات:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

الموضوعات:

Fig 10 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 5 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 6 - حسب Farshid Maleki (20521649)

الموضوعات:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

الموضوعات:

Fig 1 - حسب Miaomiao Ma (2475883)

الموضوعات: